Mesa Laboratories Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

false 0000724004 0000724004 2024-04-05 2024-04-05

 

 

Washington, D.C. 20549   

 

 

 

 

 

Date of Report (Date of earliest event reported): April 5, 2024

 

MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

 

 

 

 

Registrant’s telephone number, including area code: 303-987-8000

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Securities registered under Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

 

On April 5, 2024, Mesa Laboratories, Inc. (the “Company” “we” “us” or “our”) amended and restated its senior secured credit agreement (the “Credit Agreement”) with a syndicate of banks led by JPMorgan Chase Bank, N.A., as administrative agent.

 

The Credit Agreement has been modified to (among other changes):

 

The Company maintains its access to the senior secured revolving credit facility (the “Revolver”), allowing access to up to $125.0 of borrowings. Both the Term Loan and the Revolver bear interest at a rate of SOFR plus an applicable margin ranging from 1.5% to 3.5%, depending on the Company’s total net leverage ratio.

 

As of the date of this Form 8-K, $75.0 million is outstanding under the Term Loan, and $50.5 million is outstanding under the Revolver.

 

The proceeds of the Credit Agreement loans may be used to refinance certain existing indebtedness of the Company and to finance working capital needs and general corporate purposes of the Company in the ordinary course of business, including permitted acquisitions.

 

The foregoing description of the terms of the amended and restated Credit Agreement is qualified by reference to the text of the agreement, a copy of which is attached as Exhibit 10.1 hereto.

 

The lenders party to the Credit Agreement or their affiliates have provided from time to time, and may provide in the future, investment and commercial banking and financial advisory services to the Company and its affiliates in the ordinary course of business, for which they have received, and may receive in the future, customary fees and commissions.

 

 

On April 8, 2024, the Company issued a press release announcing the entry into the Credit Agreement and the repurchases of the 2025 Notes described in Item 8.01 below. A copy of the press release is attached as Exhibit 99.1 hereto. The press release is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

 

Immediately following the completion of the amendment and restatement of the Credit Agreement, on April 5, 2024, Mesa entered into separate, privately negotiated purchase agreements (the “Purchase Agreements”) with a limited number of holders of its outstanding 2025 Notes. Pursuant to the Purchase Agreements, the Company will purchase $75.0 million in aggregate principal amount of the 2025 Notes for an aggregate cash purchase price of approximately $71.25 million excluding accrued and unpaid interest.

 

The 2025 Notes repurchases are expected to close on or about April 11, 2024, subject to customary closing conditions. Immediately following the closing, approximately $97.5 million aggregate principal amount of the 2025 Notes will remain outstanding.

 

 

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.